Phase I - Completed
The University of Sydney Health and Medical Research Strategic Review has reached the end of Phase I. During Phase I we have been collecting submissions, which have been about highlighting issues that exist in relation to the terms of reference. More than 140 individual submissions have been received, we’ve conducted many interviews with a range of stakeholders and started a series of consultation workshops. Through this process we have logged more than 400 issues, which have been grouped into ten themes. The issues we have logged
University of Sydney Health and Medical Research Strategic Review Issues paper (PDF, 1.3MB).
Phase II - Completed
Phase II has now been completed the and we are inviting submissions for responses to the Discussion paper by 21 January 2013. We will also continue the face to face interviews with invited stakeholders and we will be facilitating additional consultation workshops.
University of Sydney Health and Medical Research Strategic Review Discussion paper (PDF, 2.3MB)
The final phase of the Review has now begun. We are calling for responses to the Discussion Paper. Your responses to the Discussion Paper along with the rest of the information collected will inform the development of the Final Report which is due to be released in March 2013.
There are several ways you can submit your response to the Discussion Paper. The simplest and most concise method is to use the Wills Review online submission form. Alternatively, you can make a submission via email to the mailbox.
Making a submission
Make an online submission – you can do this by completing the online form.
Make a submission via email – Your email should be sent to . Submissions can be any length. If a submission is more than two pages, please provide an executive summary that is less than half a page articulating the main points you wish to make and provide subheadings in the body of the submission.
We will accept submissions throughout the process, however please note the dates for the publication of the issues paper, discussion paper, draft report and final report.
Submissions received at least one week ahead of a publication date can be considered in the drafting of the paper at any given stage of the review.
Please indicate if you wish to have your submission posted on the web site. You may request the submission be not distributed beyond the Advisory Committee.
Submitting an issue
If there is an issue that you can’t find on the issues log (pdf 217kb), you are still able to submit issues for the consideration of the review by sending an email to the Wills Review mailbox .
We will accept submissions throughout the process, however please note the dates for the publication of the issues paper, discussion paper, draft report and final report. Submissions received on or before the deadline date can be considered in the drafting of the paper at stage of the review.
Conditions for the lodgement of submissions
The Review Committee will not consider anonymous submissions.
The Review Committee reserves the right to edit, remove, not to publish, to request removal by you, or to send back to you material in a submission that:
(a) is libellous/defamatory;
(b) infringes another party’s copyright; or
(c) is published in breach of privacy requirements.
Personal information you provide is collected in order for the Review Committee to take submissions in accordance with the Committee's Terms of Reference. Personal information will only be used for the purposes of the Review and will not be otherwise disclosed without your consent, unless authorised or required by law. The Review will only publish personal information on this site if it has been collected for this purpose with your knowledge or if you have consented to the disclosure. When giving such consent you should be aware that information published on this site is accessible worldwide, that it will be indexed by search engines and that it may be copied and used by any web user. This means that, once the information is published on this site, we will have no control over its subsequent use and disclosure.
The ownership of all Intellectual Property Rights vest in the submitter. The submitter grants to the Review Committee a permanent, royalty-free licence to use and adapt material in the Submission for the purposes of the Review, and only for the Review.